TP53 and head and neck cancer: In the study by Jay O. Boyle [29], the incidence of p53 mutations was detected in 19 percent of non-invasive lesions and 43 percent of invasive carcinomas, indicating that p53 mutations increased in preceding invasion in primary head and neck cancer.